The behavior of Italian allergists in prescribing allergen immunotherapy for house dust mites allergy

Written by Immunotherapy
Immunology and infectious diseases Journal articles Outcomes research Real-world evidence

Researchers have conducted a web survey on Italian allergists who commonly prescribe allergen immunotherapies (AITs) in clinical practice, to discover the current behavior in prescribing and managing AIT in patients with house dust mites (HDM) allergy. The meeting ‘Clinical Evidence, Extracts Quality and Biotechnology Innovation in Allergen Immunotherapy’ (October 1, 2017, Trieste, Italy) involved a group of approximately 50 Italian allergists, particularly expert in allergen immunotherapy (AIT) practice. The main topic concerned house dust mites (HDM) allergy, as it is a very common cause of allergic rhinitis and asthma. In deed, HDM allergy is very frequent and represents the main...

To view this content, please register now for access

It's completely free